Abstract
BACKGROUND: Although the infection rate of COVID-19 is very high, all the patients getting infected don't always die or go through brutal states. This indicates there may be some factors that possibly boost the severity of COVID-19. OBJECTIVE: We intend to identify some probable risk factors that are responsible for the severity of COVID-19 using a meta-analysis. METHODS: The literature exploration lasted up to 18 April 2020 and through PubMed, Google Scholar, EMBASE, and Cochrane Library we have identified 10 pertinent publications. To paraphrase the outcomes of autonomous researches, we have performed a random-effect meta-analysis. RESULTS: A total of 2272 patients' information was extracted from the selected literature. We have found sex (male) (Risk ratio [RR] =1.29 [1.07; 1.54]), hypertension (RR=1.79 [1.57; 2.04]), diabetes (RR=1.57 [1.25; 1.98]), fatigue or myalgia (RR=1.17 [1.02; 1.35]), and smoking history (RR=1.71 [1.25; 2.35]) are potential risk factors for the severity of COVID-19. We found fever (RR=1.21 [0.66 to 2.22]), cough ([1.13,[0.98 to 1.30]), and diarrhea (RR=1.14 [0.93 to 1.40]) as insignificant risk factors for COVID-19 severity. CONCLUSION: The finding of this research may be beneficial to identify patients with higher risks to provide additional medical attention from the very beginning of the treatment.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The studies are available online and full-text accessible.
